Context Therapeutics Inc
CNTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$261.86M
Close$
$0.69
66.2% downside
Current Fair Value
66.2% downsideOvervalued by 66.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $261.86 Million |
|---|---|
| Enterprise Value | $207.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.38 |
| Beta | 1.57 |
| Outstanding Shares | 95,183,718 |
Return
| Return on Equity | -77.06% |
|---|---|
| Return on Assets | -68.34% |
| Return on Invested Capital | -81.39% |
Valuation & Multiples
| P/E Ratio | -6.74 |
|---|---|
| PEG | -7.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.88 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.0326▲ 203.26% |
|---|---|
| Total Calls | 20,220▲ Infinity% |
| Total Puts | 41,100▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 77.93%▲ 9.43% |
|---|---|
| Total Invested | $194.34M▲ 102.77% |
| Investors Holding | 61▲ 19.00% |
ESG Score
No data